Selenium is inversely associated with bladder cancer risk: A report from the Belgian case-control study on bladder cancer

International Journal of Urology

Volumn 13, Issue 9, 2006, Pages 1180-1184

  Kellen, Eliane ^a,d   Zeegers, Maurice ^a,b   Buntinx, Frank ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Centrum voor huisartsgeneeskunde   (Belgium)

Author keywords

Bladder neoplasm; Case control study; Selenium

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; RETINOL; SELENIUM;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CALCULATION; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; FRUIT; GENDER; GROUPS BY AGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; VEGETABLE; VITAMIN SUPPLEMENTATION;

AGED; BELGIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SELENIUM; URINARY BLADDER NEOPLASMS;

EID: 33748765212     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01526.x     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
2. Zeegers MP, Tan FE, Dorant E, van den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-9.
3. Kogevinas M, Trichopoulos D. Urinary bladder cancer. In: Adami HO, Hunter D, Trichopoulos D (eds.). Textbook of Cancer Epidemiology. Oxford University Press, New York, 2002; 446-66.
4. Zeng H. Selenite and selenomethionine promote HL-60 cell cycle progression. J. Nutr. 2002; 132: 674-9.
5. Barceloux DG. Selenium. J. Toxicol. Clin. Toxicol. 1999; 37: 145-72.
6. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-41.
7. Rayman MP. Dietary selenium: time to act. BMJ 1997; 314: 387-8.
8. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in U.S. counties. Arch. Environ. Health 1991; 46: 37-42.
9. Combs GF Jr. Current evidence and research needs to support a health claim for selenium and cancer prevention. J. Nutr. 2005; 135: 343-7.
10. Jacobs ET, Jiang R, Alberts DS et al. Selenium and colorectal adenoma: results of a pooled analysis. J. Natl. Cancer Inst. 2004; 96: 1669-75.
11. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol. Biomarkers Prev. 2004; 13: 771-8.
12. Combs GF Jr. Status of selenium in prostate cancer prevention. Br. J. Cancer 2004; 91: 195-9.
13. Zeegers MP, Goldbohm RA, Bode P, van den Brandt PA. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 1292-7.
14. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989; 49: 6144-8.
15. Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J. Natl. Cancer Inst. 1987; 79: 103-8.
16. Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004; 93: 863-6.
17. Knekt P, Aromaa A, Maatela J et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst. 1990; 82: 864-8.
18. Michaud DS, Hartman TJ, Taylor PR et al. No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 1505-6.
19. Garland M, Morris JS, Stampfer MJ et al. Prospective study of toenail selenium levels and cancer among women. J. Natl. Cancer Inst. 1995; 87: 497-505.
20. Michaud DS, De VI, Morris JS, Giovannucci E. Toenail selenium concentrations and bladder cancer risk in women and men. Br. J Cancer 2005; 93: 804-6.
21. Kamat AM, Lamm DL. Chemoprevention of urological cancer. J. Urol. 1999; 161: 1748-60.
22. Kellen E, Zeegers MP, Lousbergh D, Paulussen A, Buntinx F. A Belgian case control study on bladder cancer: rationale and design. Arch. Public Health 2005; 63: 17-34 (in press).
23. Iacoviello L, Arnout J, Buntinx F et al. Dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction. The IMMIDIET Study. Nutr. Metab. Cardiovasc. Dis. 2001; 11: 122-6.
24. StataCorp. Stata Statiscal Software, 8.0. Texas, College Station, TX, 2003.
25. Kocyigit A, Erel O, Gur S. Effects of tobacco smoking on plasma selenium, zinc, copper and iron concentrations and related antioxidative enzyme activities. Clin. Biochem. 2001; 34: 629-33.
26. Robberecht H, Deelstra H. Factors influencing blood selenium concentration values: a literature review. J. Trace Elem. Elect. H. 1994; 8: 129-43.
27. Kornitzer M, Valente F, De Bacquer D, Neve J, De Backer G. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population. Eur. J. Clin. Nutr. 2004; 58: 98-104.
28. Neve J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J. Trace Elem. Med. Biol. 1995; 9: 65-73.
29. Levander OA. Considerations on the assessment of selenium status. Fed. Proc. 1985; 44: 2579-83.
30. Rothman KJ, Greenland S. Modern Epidemiology. Lippincott William and Wilkins, Philadelphia, 1998.
31. Longnecker MP, Stram DO, Taylor PR et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996; 7: 384-90.
32. Satia JA, King IB, Morris JS, Stratton K, White E. Toenail and plasma levels as biomarkers of selenium exposure. Ann. Epidemiol. 2006; 16: 53-8.
33. Hunter DJ, Morris JS, Chute CG et al. Predictors of selenium concentration in human toenails. Am. J. Epidemiol. 1990; 132: 114-22.
34. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol. Biomarkers Prev. 1993; 2: 107-12.
35. Karita K, Sasaki S, Ishihara J, Tsugane S. Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC study to assess selenium intake: comparison with dietary records and blood levels. J. Epidemiol. 2003; 13: S92-S97.
36. Lu J. Apoptosis and angiogenesis in cancer prevention by selenium. Adv. Exp. Med. Biol. 2001; 492: 131-45.
37. Raich PC, Lu J, Thompson HJ, Combs GF Jr. Selenium in cancer prevention: clinical issues and implications. Cancer Invest. 2001; 19: 540-53.
38. Schrauzer GN. Anticarcinogenic effects of selenium. Cell. Mol. Life Sci. 2000; 57: 1864-73.
39. Combs GF Jr, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. Biofactors 2001; 14: 153-9.